Credit funds and accounts managed by KKR agreed to provide a credit facility of up to $150 million to Jet Edge International, a provider of full-service private aviation that operates a fleet of managed Challenger and Gulfstream aircraft in the United States.
Cloudera entered into a definitive agreement to be acquired by affiliates of Clayton, Dubilier & Rice and KKR in an all-cash transaction valued at approximately $5.3 billion. J.P. Morgan, Bank of America and KKR Capital Markets committed to provide debt financing for the transaction.
Craig Farr joined Apollo Global Management as a senior partner to lead the firm’s capital solutions activities. In this newly created role, Farr will spearhead Apollo’s centralized origination, structuring and distribution platform.
KKR appointed Jim Lees and Vaibhav Piplapure managing directors for its global private credit team to augment asset-based finance investing opportunities in the specialty lending and private asset-based finance markets.
Sycamore Partners, KKR, Blackstone Credit and other first lien term lenders delivered $225 million in new capital for Belk in the company’s restructuring support agreement.
CIT’s healthcare finance group arranged a $75 million senior secured asset-based credit facility for One Call Corporation, a Jacksonville, FL-based service provider to the workers’ compensation industry.
Callodine Group agreed to acquire Gordon Brothers Finance Company. As a result, Gordon Brothers Finance Company changed its name to Callodine Commercial Finance. The acquisition is being funded in part by financing from KKR, East Asset Management and Axar Capital Management.
Through its global direct lending platform, Ares Management is serving as the lead arranger for a £1.875 billion ($2.34 billion) financing commitment to The Ardonagh Group, an independent insurance broker.
Coty signed a definitive agreement with KKR as part of a transformation that will deleverage Coty’s balance sheet, streamline its operations and strengthen its leadership team. KKR is investing $1 billion directly into Coty through the issuance of convertible preferred shares.
An affiliate of KKR signed a $170 million term loan agreement with Aimmune Therapeutics, a biopharmaceutical company developing treatments for potentially life-threatening food allergies.